Invesco S&P SmallCap Consumer Staples ETF (PSCC)
NASDAQ: PSCC · Real-Time Price · USD
37.42
+0.13 (0.36%)
Aug 28, 2026, 4:00 PM EDT - Market closed
0.36% (1D)
| Assets | $40.16M |
| Expense Ratio | 0.29% |
| PE Ratio | 18.36 |
| Shares Out | 1.06M |
| Dividend (ttm) | $0.60 |
| Dividend Yield | 1.61% |
| Ex-Dividend Date | Jun 22, 2026 |
| Payout Frequency | Quarterly |
| Payout Ratio | 29.64% |
| Volume | 3,937 |
| Open | 37.40 |
| Previous Close | 37.29 |
| Day's Range | 37.38 - 37.53 |
| 52-Week Low | 30.60 |
| 52-Week High | 38.22 |
| Beta | 0.61 |
| Holdings | 29 |
| Inception Date | Apr 7, 2010 |
About PSCC
Fund Home PageThe Invesco S&P SmallCap Consumer Staples ETF (PSCC) is an exchange-traded fund that mostly invests in consumer staples equity. The fund tracks a market-cap-weighted index of consumer staples stocks selected from the S&P SmallCap 600. PSCC was launched on Apr 7, 2010 and is issued by Invesco.
Asset Class Equity
Category Consumer Defensive
Stock Exchange NASDAQ
Ticker Symbol PSCC
ETF Provider Invesco
Index Tracked S&P Small Cap 600 Capped Consumer Staples
Top 10 Holdings
64.26% of assets| Name | Symbol | Weight |
|---|---|---|
| Conagra Brands, Inc. | CAG | 12.19% |
| Lamb Weston Holdings, Inc. | LW | 11.02% |
| PriceSmart, Inc. | PSMT | 6.91% |
| The Campbell's Company | CPB | 6.80% |
| Cal-Maine Foods, Inc. | CALM | 5.79% |
| Freshpet, Inc. | FRPT | 4.90% |
| The Chefs' Warehouse, Inc. | CHEF | 4.75% |
| The Vita Coco Company, Inc. | COCO | 4.32% |
| WD-40 Company | WDFC | 3.86% |
| Interparfums, Inc. | IPAR | 3.72% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 22, 2026 | $0.11584 | Jun 26, 2026 |
| Mar 23, 2026 | $0.13003 | Mar 27, 2026 |
| Dec 22, 2025 | $0.14135 | Dec 26, 2025 |
| Sep 22, 2025 | $0.21675 | Sep 26, 2025 |
| Jun 23, 2025 | $0.20093 | Jun 27, 2025 |
| Mar 24, 2025 | $0.17199 | Mar 28, 2025 |
Performance
PSCC had a total return of 8.23% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.99%.
News
One Biosciences Receives BOOST Funding From Paris-Saclay Cancer Cluster to Advance the First Single-Cell Assay Approach for ADC Therapies
PARIS--(BUSINESS WIRE)-- #adc--One Biosciences receives Paris-Saclay Cancer Cluster (PSCC) BOOST grant to develop first single-cell assay for antibody-drug conjugates therapies.
2 months ago - Business Wire
